Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotic resistance in children with streptococcal pharyngitis
IRCT20200720048140N1Phase 2Completed
- Sponsor
- Kashan University of Medical Sciences
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of Benzathine penicillin, azithromycin, clindamycin and amoxicillin in streptococcal pharyngitis (4 arms), sponsored by Kashan University of Medical Sciences. Primary endpoints: Antibiotic resistance to studied antibiotics and Better treatment choice. Started May 2018; status: completed.
02
Drugs
Benzathine penicillinazithromycinclindamycinamoxicillin
03
Conditions
streptococcal pharyngitis
Beyond the preview
Go deeper on IRCT20200720048140N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200720048140N1.